• Mashup Score: 0

    About this Tool This clinical decision support tool (CDST) is designed to assist clinicians in selecting cytomegalovirus (CMV) therapy for solid organ transplant (SOT) patients (lung, heart, liver, kidney, pancreas, or intestine) or hematopoietic cell transplant (HCT) patients 12 years or older with suspected or confirmed antiviral resistant or refractory CMV infection or disease. The definitions…

    Tweet Tweets with this article
    • Have you used the Clinical Decision Support Tool (CDST)? This novel tool will help you select optimal treatment for SOT or HCT patients with CMV infection or disease. Learn more 👉 https://t.co/l2gVGFaDHn #TransplantTwitter #SolidOrganTransplant #tools https://t.co/GExo7EknFF

  • Mashup Score: 9

    The American Gastroenterological Association has Officially Endorsed this Clinical Decision Support Tool.The American Gastroenterological Association has Officially Endorsed this Clinical Decision Support Tool.The IBD Clinical Decision Support Tool was developed by Parambir Dulai, MD in conjunction with the US Health Outcomes Consortium, a collaboration of leading IBD centers across the US.This…

    Tweet Tweets with this article
    • 📣 Calling all #GI providers if you ever take care of a patient with #IBD you should be using in clinic @AmerGastroAssn @PDulaiMD Crohn’s Disease & Ulcerative Colitis Clinical Decision Support Tool https://t.co/fx4rnNrO3Y ✔️Save this on your desktop ✔️Open tool with patient https://t.co/3GJ3uOWTZa

  • Mashup Score: 0

    About this Tool This clinical decision support tool (CDST) is designed to assist clinicians in selecting cytomegalovirus (CMV) therapy for solid organ transplant (SOT) patients (lung, heart, liver, kidney, pancreas, or intestine) or hematopoietic cell transplant (HCT) patients 12 years or older with suspected or confirmed antiviral resistant or refractory CMV infection or disease. The definitions…

    Tweet Tweets with this article
    • TTS has endorsed the Clinical Decision Support Tool (CDST) for Resistant/Refractory CMV in Transplantation. This must-have tool will assist transplant clinicians select optimal treatment for patients with CMV! Learn More 👉 https://t.co/b28uLqM9CE https://t.co/8ojGpdTzFx

  • Mashup Score: 1

    About this Tool This clinical decision support tool (CDST) is designed to assist clinicians in selecting cytomegalovirus (CMV) therapy for solid organ transplant (SOT) patients (lung, heart, liver, kidney, pancreas, or intestine) or hematopoietic cell transplant (HCT) patients 12 years or older with suspected or confirmed antiviral resistant or refractory CMV infection or disease. The definitions…

    Tweet Tweets with this article
    • TTS has endorsed the Clinical Decision Support Tool (CDST) for Resistant/Refractory CMV in Transplantation. This must-have tool will assist transplant clinicians select optimal treatment for patients with CMV! Learn More 👉 https://t.co/b28uLqM9CE https://t.co/28yxycrX3Q